The Role of the Mucosal Immune System in Ulcerative Colitis and Crohn's Disease
- 1 January 1994
- book chapter
- Published by Elsevier
Abstract
No abstract availableThis publication has 153 references indexed in Scilit:
- Plasma and tissue interleukin-2 receptor levels in inflammatory bowel diseaseClinical and Experimental Immunology, 1990
- Enhanced Local Production of Complement Components in the Small Intestines of Patients with Crohn's DiseaseNew England Journal of Medicine, 1990
- Fast atom bombardment-mass spectrometric identification of molecular species of platelet-activating factor produced by stimulated human polymorphonuclear leukocytesBiochemical and Biophysical Research Communications, 1985
- Evidence for production of 1-acyl-2-acetyl-sn-glyceryl-3-phosphorylcholine concomitantly with platelet-activating factorBiochemical and Biophysical Research Communications, 1985
- T lymphocyte subsets in inflammatory bowel disease: peripheral blood.Gut, 1983
- Platelet Activating Factor (PAF) induces the oxidative burst in macrophagesInternational Journal of Immunopharmacology, 1983
- Suppression of human polymorphonuclear function after intravenous infusion of prostaglandin E1Prostaglandins and Medicine, 1981
- Studies of prostaglandins and sulphasalazine in ulcerative colitisProstaglandins and Medicine, 1981
- Effect of anti-inflammatory drugs and agents that elevate intracellular cyclic AMP on the release of toxic oxygen metabolites by phagocytes: Studies in a model of tissue-bound IgGClinical Immunology and Immunopathology, 1978
- Effect of Prostaglandin E2 on Adjuvant ArthritisNature, 1969